Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi Ramps Up In Rare Diseases With Inhibrx Buy

Jan 23 2024

• By Kevin Grogan

Sanofi — • Source: Sanofi

Related Content

Sanofi Tries To Win Skeptics Over To Its Immunology Masterplan

Dec 07 2023

Sanofi Stock Slides On Lower Profit Forecast And Consumer Health Spinoff Plan

Oct 27 2023

Sanofi Eyes External Deals On Top Of Promising Pipeline

Oct 30 2023

Biohaven Relaunches As Biohaven Ltd. After Pfizer Buyout Closes

Oct 04 2022

Related Companies

Sanofi

Inhibrx, Inc.

Pfizer Inc.

Arrowhead Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Mereo BioPharma Group plc

Additional Topics

M & A Rare Diseases Commercial Business Strategies Inflammation BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window